Metraipolis › archive › dc_3cc284fc6fdb
Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial — Europe PMC PMID:42253103
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42253103
- DOI
- 10.1111/hel.70146
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T21:18:41.313Z
- SHA-256 of the archived text
92039693747b333c44c27edebf80e85827b8dfb89aff74314f1cd5b3378284fb- Stable URL of this page
https://metraipolis.com/documento/dc_3cc284fc6fdb
How to cite
Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial — Europe PMC PMID:42253103 — Europe PMC (en), https://europepmc.org/article/MED/42253103 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cc284fc6fdb (Metraipolis archive dc_3cc284fc6fdb, sha256 92039693747b333c44c27edebf80e85827b8dfb89aff74314f1cd5b3378284fb)
BibTeX
@misc{dc3cc284fc6fdb,
title = {Efficacy and Safety of Fexuprazan-Based Modified High-Dose Dual Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial — Europe PMC PMID:42253103},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42253103},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cc284fc6fdb; sha256 92039693747b333c44c27edebf80e85827b8dfb89aff74314f1cd5b3378284fb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42253103. Agents can read the archived copy with the MCP tool read_document.